HomeNewsIndiaFirst section of Delhi Metro Ph-IV to open by July 2024, fresh targets set due to Covid: DMRC chief
Trending Topics

First section of Delhi Metro Ph-IV to open by July 2024, fresh targets set due to Covid: DMRC chief

In an interview to PTI, Kumar also said that besides commissioning of a small 2.5-3 km segment of the Janakpuri West-R K Ashram Marg corridor, the whole Majlis Park-Maujpur corridor is planned to be opened by March 2025.

November 04, 2023 / 16:36 IST
Story continues below Advertisement
The work on Ph-IV, which had begun in December 2019, was hit due to the outbreak of the COVID-19 pandemic
The work on Ph-IV, which had begun in December 2019, was hit due to the outbreak of the COVID-19 pandemic

Due to impact of the COVID-19 pandemic, "fresh targets" have been set for Ph-IV project of the Delhi Metro, and the first section of a priority corridor is planned to be opened by July 2024, DMRC chief Vikas Kumar said.

In an interview to PTI, Kumar also said that besides commissioning of a small 2.5-3 km segment of the Janakpuri West-R K Ashram Marg corridor, the whole Majlis Park-Maujpur corridor is planned to be opened by March 2025.

Story continues below Advertisement

The managing director of the Delhi Metro Rail Corporation (DMRC) said the construction of the Ph-IV has brought many firsts for the country, and "beam technology-enabled TBMs" are being used in the phase to assess strata layers in advance so that "there are no surprises" during the drilling process. The work on Ph-IV, which had begun in December 2019, was hit due to the outbreak of the COVID-19 pandemic in March 2020 in Delhi.

At present, the DMRC is undertaking construction work on 65.2 km of three priority corridors spanning 45 stations under the project Janakpuri West-RK Ashram Marg (28.92 km), Majlis Park-Maujpur (12.55 km), which are extensions of the already operational Magenta Line and Pink Line, and Aerocity-Tughlakabad (23.62 km) that is being built as 'Silver Line', connecting the operational Violet Line and Airport Line from the respective ends.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show